Mulroy Michael H. has filed 3 insider transactions across 1 company since July 2024.
Most recent transaction: a grant/award of 75000 shares of Lineage Cell Therapeutics, Inc. ($LCTX) on July 01, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 1, 2025 | Lineage Cell Therapeutics, Inc. | $LCTX | Mulroy Michael H. | Not found | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 220,416,326 | 9999.99% | 0.03% |
| Nov. 22, 2024 | Lineage Cell Therapeutics, Inc. | $LCTX | Mulroy Michael H. | Not found | P | Common Shares | 40000 | $0.57 | 298,555.0000 | 174,987,000 | 15.47% | 0.02% |
| July 1, 2024 | Lineage Cell Therapeutics, Inc. | $LCTX | Mulroy Michael H. | Not found | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 174,987,000 | 9999.99% | 0.04% |